APOL1 , α-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia
Open Access
- 22 September 2016
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 102 (1), e1-e6
- https://doi.org/10.3324/haematol.2016.154153
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemiaBritish Journal of Haematology, 2013
- Severe Painful Vaso-Occlusive Crises and Mortality in a Contemporary Adult Sickle Cell Anemia Cohort StudyPLOS ONE, 2013
- An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin LevelScience, 2013
- Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypesAmerican Journal of Hematology, 2013
- MYH9 and APOL1 are both associated with sickle cell disease nephropathyBritish Journal of Haematology, 2011
- A New Equation to Estimate Glomerular Filtration RateAnnals of Internal Medicine, 2009
- DNA polymorphisms at the BCL11A , HBS1L-MYB , and β- globin loci associate with fetal hemoglobin levels and pain crises in sickle cell diseaseProceedings of the National Academy of Sciences of the United States of America, 2008
- Global epidemiology of haemoglobin disorders and derived service indicatorsBulletin of the World Health Organization, 2008
- Evidence that Microdeletions in the α Globin Gene Protect Against the Development of Sickle Cell Glomerulopathy in HumansJournal of the American Society of Nephrology, 1999
- The Interaction of Alpha-Thalassemia and Homozygous Sickle-Cell DiseaseThe New England Journal of Medicine, 1982